Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.466 DKK 2.23% Market Closed
Market Cap: 629.9m DKK

EV/OCF
Enterprise Value to OCF

-8.1
Current
-9
Median
4.9
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-8.1
=
Enterprise Value
556.5m DKK
/
Operating Cash Flow
-68.7m DKK
Market Cap EV/OCF
DK
Bioporto A/S
CSE:BIOPOR
629.9m DKK -8.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -229 119.7
US
Abbvie Inc
NYSE:ABBV
378B USD 23
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 18.7
US
Gilead Sciences Inc
NASDAQ:GILD
138.7B USD 14.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
131.5B USD -251.7
US
Epizyme Inc
F:EPE
94.1B EUR -491.4
AU
CSL Ltd
ASX:CSL
120B AUD 28.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.4B USD 11.7
US
Seagen Inc
F:SGT
39.3B EUR -77
NL
argenx SE
XBRU:ARGX
32.9B EUR -126.3
 
DK
Bioporto A/S
CSE:BIOPOR
Average EV/OCF: 19.2
Negative Multiple: -8.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -229 119.7
US
Abbvie Inc
NYSE:ABBV
23
US
Amgen Inc
NASDAQ:AMGN
18.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -251.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -491.4
AU
CSL Ltd
ASX:CSL
28.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -77
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.3

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A